ArticlePloS one2022

Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA.

Jonathan Poh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.